Chairman

Marco is a successful entrepreneur and former CEO and Chairman of Paragon Biosciences, Inc., a CDMO specialized in product development and GMP manufacturing of vaccines and viral vectors for gene therapy. Paragon was acquired by Catalent Pharma in 2019 for $1.2 B.

Board Member

Mr. Berens is Chairman and President of Wexford Science and Technology. His experience includes the development of 18 innovation communities in partnership with leading research universities around the country offering state-of-the-art research and laboratory spaces.

Board Member

Mr. Kohr is a founding member and Chief Executive Officer of Evergreen Advisors, LLC. He has over 30 years of experience in advising early-stage growth and middle-market companies on finance, recapitalization and exit strategies.